| Dr Bindu Lal, MD | |
|
14 Sycamore Way, Branford, CT 06405-6551 | |
| (203) 483-2630 | |
| Not Available |
| Full Name | Dr Bindu Lal |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 26 Years |
| Location | 14 Sycamore Way, Branford, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598935389 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 047201 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Waterbury Hospital | Waterbury, CT | Hospital |
| Middlesex Hospital | Middletown, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Middlesex Hospital | 5092611731 | 202 |
| State Of Connecticut | 8022915677 | 194 |
News Archive
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company, announced today the initiation of a Phase Ib clinical trial to study the safety and efficacy of RX-3117 in cancer patients with solid tumors.
An international team of researchers, including scientists from the University of Dundee have announced that cyanobacteria (blue-green algae) found throughout the world may produce a toxin linked to certain types of neurological disease.
Researchers have identified several new genes responsible for Alzheimer's disease (AD) including those leading to functional and structural changes in the brain and elevated levels of AD proteins in cerebrospinal fluid (CSF).
According to a new study released by The State Farm Center for Women and Financial Services at The American College, women – whether they're working or a stay-at-home mom, single or married – women are most at risk both physically and financially when it comes to disability.
› Verified 1 days ago
| Entity Name | Middlesex Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760454334 PECOS PAC ID: 5092611731 Enrollment ID: O20031211000843 |
News Archive
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company, announced today the initiation of a Phase Ib clinical trial to study the safety and efficacy of RX-3117 in cancer patients with solid tumors.
An international team of researchers, including scientists from the University of Dundee have announced that cyanobacteria (blue-green algae) found throughout the world may produce a toxin linked to certain types of neurological disease.
Researchers have identified several new genes responsible for Alzheimer's disease (AD) including those leading to functional and structural changes in the brain and elevated levels of AD proteins in cerebrospinal fluid (CSF).
According to a new study released by The State Farm Center for Women and Financial Services at The American College, women – whether they're working or a stay-at-home mom, single or married – women are most at risk both physically and financially when it comes to disability.
› Verified 1 days ago
| Entity Name | State Of Connecticut |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841225489 PECOS PAC ID: 8022915677 Enrollment ID: O20040319000427 |
News Archive
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company, announced today the initiation of a Phase Ib clinical trial to study the safety and efficacy of RX-3117 in cancer patients with solid tumors.
An international team of researchers, including scientists from the University of Dundee have announced that cyanobacteria (blue-green algae) found throughout the world may produce a toxin linked to certain types of neurological disease.
Researchers have identified several new genes responsible for Alzheimer's disease (AD) including those leading to functional and structural changes in the brain and elevated levels of AD proteins in cerebrospinal fluid (CSF).
According to a new study released by The State Farm Center for Women and Financial Services at The American College, women – whether they're working or a stay-at-home mom, single or married – women are most at risk both physically and financially when it comes to disability.
› Verified 1 days ago
| Entity Name | Middlesex Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760451041 PECOS PAC ID: 5092611731 Enrollment ID: O20060912000506 |
News Archive
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company, announced today the initiation of a Phase Ib clinical trial to study the safety and efficacy of RX-3117 in cancer patients with solid tumors.
An international team of researchers, including scientists from the University of Dundee have announced that cyanobacteria (blue-green algae) found throughout the world may produce a toxin linked to certain types of neurological disease.
Researchers have identified several new genes responsible for Alzheimer's disease (AD) including those leading to functional and structural changes in the brain and elevated levels of AD proteins in cerebrospinal fluid (CSF).
According to a new study released by The State Farm Center for Women and Financial Services at The American College, women – whether they're working or a stay-at-home mom, single or married – women are most at risk both physically and financially when it comes to disability.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bindu Lal, MD 115 Summer Ln, North Haven, CT 06473-3569 Ph: (203) 848-7784 | Dr Bindu Lal, MD 14 Sycamore Way, Branford, CT 06405-6551 Ph: (203) 483-2630 |
News Archive
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company, announced today the initiation of a Phase Ib clinical trial to study the safety and efficacy of RX-3117 in cancer patients with solid tumors.
An international team of researchers, including scientists from the University of Dundee have announced that cyanobacteria (blue-green algae) found throughout the world may produce a toxin linked to certain types of neurological disease.
Researchers have identified several new genes responsible for Alzheimer's disease (AD) including those leading to functional and structural changes in the brain and elevated levels of AD proteins in cerebrospinal fluid (CSF).
According to a new study released by The State Farm Center for Women and Financial Services at The American College, women – whether they're working or a stay-at-home mom, single or married – women are most at risk both physically and financially when it comes to disability.
› Verified 1 days ago
Dr. Ellen Joy Hoffman, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 342 Harbor St, Branford, CT 06405 Phone: 203-481-4248 | |
Laura Gault, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 342 Harbor St, Branford, CT 06405 Phone: 203-481-4248 Fax: 203-483-7727 | |
Dr. Haeja Grace Kim, M.D, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 92 Rogers St Unit 4, Branford, CT 06405 Phone: 203-488-5817 | |
Mr. James Joseph Ciarcia, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 388 East Main St., #3, Branford, CT 06405 Phone: 203-483-5300 Fax: 203-483-6400 | |
John Adams Gallalee, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 625 E Main St, Branford, CT 06405 Phone: 203-488-0440 | |
Tamara Vanderwal, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 342 Harbor St, Branford, CT 06405 Phone: 203-481-4248 |